688046 药康生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.3965.1577.74711.91817.316
总资产报酬率 ROA (%)1.1484.2656.5799.95512.895
投入资产回报率 ROIC (%)1.2154.5977.12811.02215.361

边际利润分析
销售毛利率 (%)63.05561.99267.61171.38374.330
营业利润率 (%)17.95317.37926.30833.67636.381
息税前利润/营业总收入 (%)16.61615.67123.63530.69335.815
净利润/营业总收入 (%)17.54715.98925.54131.87831.725

收益指标分析
经营活动净收益/利润总额(%)114.57889.46184.35471.65772.406
价值变动净收益/利润总额(%)4.7158.6788.8325.4377.979
营业外收支净额/利润总额(%)0.000-0.128-1.488-0.1570.035

偿债能力分析
流动比率 (X)4.3204.6064.5246.8533.687
速动比率 (X)4.1734.4604.3956.6223.530
资产负债率 (%)18.44817.02217.57212.24725.491
带息债务/全部投入资本 (%)10.5798.7916.4692.6255.665
股东权益/带息债务 (%)811.0791,006.0781,389.3163,596.7631,552.634
股东权益/负债合计 (%)442.072487.471469.088716.557292.300
利息保障倍数 (X)-12.432-9.292-10.332-10.472-61.858

营运能力分析
应收账款周转天数 (天)195.802162.536131.518105.86095.648
存货周转天数 (天)80.36569.84086.25196.87484.413